Patents by Inventor Patricia A. Bacha

Patricia A. Bacha has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Epidermal growth factor receptor targeted molecules for treatment of inflammatory arthritis
    Patent number: 5906820
    Abstract: The invention features a method for treating a patient having inflammatory arthritis, the method includes administering to the patient a molecule which is capable of specifically binding to an epidermal growth factor receptor expressed on a cell of the patient which contributes to the inflammatory arthritis of the patient, the molecule being capable of decreasing the viability of the cell.
    Type: Grant
    Filed: May 5, 1997
    Date of Patent: May 25, 1999
    Assignee: Seragen, Inc.
    Inventor: Patricia A. Bacha
  • Mammalian model of a malignant disorder
    Patent number: 5684221
    Abstract: A method for producing a mouse having a systemic malignant disease which mimics a human IL-2 expressing. T-cell malignancy, which includes administering to a mouse a mixture of passaged cells comprising cancer causing cells, the mixture having been rendered cancer causing by in vivo passage of tumor inducing cells in athymic mice.
    Type: Grant
    Filed: May 12, 1994
    Date of Patent: November 4, 1997
    Assignee: Seragen, Inc.
    Inventors: Serene E. Forte, Patricia Bacha
  • Epidermal growth factor receptor targeted molecules for treatment of inflammatory arthritis
    Patent number: 5614488
    Abstract: The invention features a method for treating a patient having inflammatory arthritis, the method includes administering to the patient a molecule which is capable of specifically binding to an epidermal growth factor receptor expressed on a cell of the patient which contributes to the inflammatory arthritis of the patient, the molecule being capable of decreasing the viability of the cell.
    Type: Grant
    Filed: September 3, 1993
    Date of Patent: March 25, 1997
    Assignee: Seragen, Inc.
    Inventor: Patricia A. Bacha
  • Polypeptide-toxin hybrid protein
    Patent number: 4468382
    Abstract: A hybrid protein toxic to cells having linear neuropeptide receptors such as TRH receptors comprising a linear neuropeptide such as TRH covalently bonded to CRM 45 is useful for treatment of tumors.
    Type: Grant
    Filed: July 15, 1982
    Date of Patent: August 28, 1984
    Assignee: New England Medical Center, Inc.
    Inventors: Patricia Bacha, Seymour Reichlin, John R. Murphy